|
|
|
|
Magnesium and VitB6 Intake Reduces Hyperexcitability in Children
SOURCE: Blaine Pharmaceuticals
11:11AM, September 23, 2005
Attention-Deficit/Hyperactivity Disorder (ADHD) impairs approximately 3 – 9% of the world’s population, and is a common and chronic disability in children. It is characterized by behavioral disorders with academic and social dysfunction and skill deficit, and its main symptoms include physical aggression and lack of control, and inattention. Standard treatments include central nervous system stimulants, tricyclic antidepressants, and monoamine oxidase inhibitors. As dietetic factors may play a significant role in the etiology of ADHD, magnesium deficiency has been implicated in hyperactivity in children. A study in the October 2004 Journal of the American College of Nutrition (2004. 23: 545S-548S) examined the effects of magnesium and vitamin B6 intake on measures of hyperexcitability in 52 children under 15 years of age.
Intra-erythrocyte magnesium levels (ERC-Mg) were found to be significantly lower (2.041± 0.279 mmol/L) in hyperexcitable subjects than in reference normals (2.2 mmol/L). The children were treated with a magnesium-B6 preparation at a dose of 6 mg/kg/day for one to six months, restoring ERC-Mg levels to normal. At four months of treatment, there was a 55% improvement in hypertony, a 70% improvement in measures of physical aggressiveness, and a 30% improvement in developmental disorders.
This study did not use Mag-Ox 400®. However, Mag-Ox 400 is the #1 doctor recommended magnesium supplement – it has four times the magnesium per tablet than other leading brands with a 35% smaller tablet. This Pharmaceutical Grade product offers a 99% dissolution level compared to 38-48% dissolution levels found in leading generics. The dosing for Mag-Ox 400 is two tablets daily.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
For additional information visit
www.magox.com
|
|
|
|
|
|